PLUR Pluri Inc
Price (delayed)
$5.56
Market cap
$38.9M
P/E Ratio
N/A
Dividend/share
N/A
EPS
-$3.69
Enterprise value
$60.71M
Pluristem Therapeutics Inc. is a leading regenerative medicine company developing novel placenta-based cell therapy product candidates. The Company has reported robust clinical trial data in multiple indications for its patented
Highlights
Pluri's revenue has soared by 90% YoY and by 13% from the previous quarter
The gross profit has grown by 36% YoY
The equity has plunged by 52% from the previous quarter
The quick ratio has contracted by 29% YoY and by 14% from the previous quarter
Key stats
What are the main financial stats of PLUR
Market
Valuations
Earnings
Shares outstanding
7M
Market cap
$38.9M
Enterprise value
$60.71M
Price to earnings (P/E)
N/A
Price to book (P/B)
N/A
Price to sales (P/S)
45.54
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
89.54
Revenue
$678,000
Gross profit
$474,000
Operating income
-$21.72M
Net income
-$19.86M
EBIT
-$20.68M
EBITDA
-$20.42M
Free cash flow
-$17.63M
Per share
Balance sheet
Liquidity
EPS
-$3.69
EPS diluted
-$3.69
Free cash flow per share
-$3.17
Book value per share
-$1.44
Revenue per share
$0.12
TBVPS
$5.56
Total assets
$30.86M
Total liabilities
$33.78M
Debt
$29.3M
Equity
-$8.03M
Working capital
$17.93M
Debt to equity
-3.65
Current ratio
5.04
Quick ratio
4.89
Net debt/EBITDA
-1.07
Margins
Efficiency
Dividend
EBITDA margin
-3,011.9%
Gross margin
69.9%
Net margin
-2,929.2%
Operating margin
-3,204%
Return on assets
-55.9%
Return on equity
N/A
Return on invested capital
-37.8%
Return on capital employed
-78.3%
Return on sales
-3,049.6%
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A
PLUR stock price
How has the Pluri stock price performed over time
Intraday
-9%
1 week
37.97%
1 month
23.56%
1 year
13.47%
YTD
30.06%
QTD
29.3%
Financial performance
How have Pluri's revenue and profit performed over time
Revenue
$678,000
Gross profit
$474,000
Operating income
-$21.72M
Net income
-$19.86M
Gross margin
69.9%
Net margin
-2,929.2%
Pluri's revenue has soared by 90% YoY and by 13% from the previous quarter
PLUR's net margin has surged by 56% year-on-year and by 20% since the previous quarter
Pluri's operating margin has surged by 53% YoY and by 13% QoQ
The gross profit has grown by 36% YoY
Growth
What is Pluri's growth rate over time
Valuation
What is Pluri stock price valuation
P/E
N/A
P/B
N/A
P/S
45.54
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
89.54
Pluri's EPS has increased by 20% YoY and by 10% QoQ
The equity has plunged by 52% from the previous quarter
Pluri's revenue has soared by 90% YoY and by 13% from the previous quarter
PLUR's P/S is 29% below its last 4 quarters average of 70.5
Efficiency
How efficient is Pluri business performance
Pluri's return on sales has surged by 51% YoY and by 19% QoQ
PLUR's return on invested capital is down by 15% year-on-year but it is up by 3.1% since the previous quarter
Pluri's return on assets has decreased by 13% YoY
Dividends
What is PLUR's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A
There are no recent dividends present for PLUR.
Financial health
How did Pluri financials performed over time
The company's total assets is 9% lower than its total liabilities
The quick ratio has contracted by 29% YoY and by 14% from the previous quarter
The current ratio has declined by 29% year-on-year and by 15% since the previous quarter
The debt to equity has dropped by 153% year-on-year but it is up by 38% since the previous quarter
The equity has plunged by 52% from the previous quarter
All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise
specified. Data from 
and Sharadar.